Long-Term Follow-Up Protocol for Subjects Treated
Research payments
$821,246
Through program year 2022, $821,246 in research payments was reported against Long-Term Follow-Up Protocol for Subjects Treated, across 63 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $237,710 | 17 |
| 2021 | Research | $583,536 | 46 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Matthew Lunning Omaha, NE Named on 3 payments
- Jordan Gauthier Seattle, WA Named on 2 payments
- Yi Lin Rochester, MN Named on 2 payments
- Vinod Parameswaran Sioux Falls, SD Named on 2 payments
- Reem Karmali Chicago, IL Named on 2 payments
- Nina Shah San Francisco, CA Named on 2 payments
- Ravi Vij Shiloh, IL Named on 2 payments
- Rex Garland Temple, TX Named on 2 payments
- Meera Mohan Milwaukee, WI Named on 1 payment
- Natalie Callander Middleton, WI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.